InvestorsHub Logo

groton68

06/30/18 2:54 PM

#232983 RE: scottsmith #232979

It could be. We have to wait for results.

Rdunn88

06/30/18 2:57 PM

#232984 RE: scottsmith #232979

P should have more sales than B if it matches or beats Otezla. Otezla reported sales of 353 million in Q1. Not sure B could be a billion dollar per/year drug unless Absssi/OM and dermatology all pan out.

https://marketrealist.com/2018/06/wall-street-analysts-are-mostly-positive-on-celgene-in-june